Bliss GVS Pharma consolidated net profit rises 214.58% in the March 2022 quarter

Sales rise 26.51% to Rs 167.06 crore

Net profit of Bliss GVS Pharma rose 214.58% to Rs 19.63 crore in the quarter ended March 2022 as against Rs 6.24 crore during the previous quarter ended March 2021. Sales rose 26.51% to Rs 167.06 crore in the quarter ended March 2022 as against Rs 132.05 crore during the previous quarter ended March 2021.

For the full year,net profit declined 78.04% to Rs 15.04 crore in the year ended March 2022 as against Rs 68.49 crore during the previous year ended March 2021. Sales rose 29.49% to Rs 747.45 crore in the year ended March 2022 as against Rs 577.21 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales167.06132.05 27 747.45577.21 29 OPM %12.0712.78 -15.8318.48 - PBDT30.7220.85 47 145.09121.36 20 PBT26.4516.58 60 127.76104.13 23 NP19.636.24 215 15.0468.49 -78

Powered by Capital Market - Live News